FDA’s drug review center adds over 100 staff in a quarter, first net gain since late 2024

The FDA’s Center for Drug Evaluation and Research (CDER) reported hiring more than 100 new employees in the most recent quarter.

This net increase is the first time the drug center has added more staff than it lost since the latter part of 2024, reversing a trend that began after significant workforce reductions in April 2025 under the previous administration.

The hiring surge suggests the agency is working to rebuild its capacity for drug review and oversight, though the article provides no details on specific roles or timelines.